Mechanistic studies on the enzymatic processing of fluorinated methionine analogs by Trichomonas vaginalis methionine γ-lyase

Ignace A Moya, Gareth D Westrop, Graham H Coombs, John F Honek

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

L-Trifluoromethionine (TFM), a potential prodrug, was reported to be toxic toward human pathogens that express L-methionine γ-lyase (MGL; EC: 4.4.1.11), a pyridoxal phosphate-containing enzyme that converts L-methionine to α-ketobutyrate, ammonia and methyl mercaptan. It has been hypothesized that the extremely reactive thiocarbonyl difluoride is produced when the enzyme acts upon TFM, resulting in cellular toxicity. The potential application of the fluorinated thiomethyl group in other areas of biochemistry and medicinal chemistry requires additional studies. Therefore a detailed investigation of the theoretical and experimental chemistry and biochemistry of these fluorinated groups (CF3S- and CF2HS-) has been undertaken to trap and identify chemical intermediates produced by enzyme processing of molecules containing these fluorinated moieties. MGL from Trichomonas vaginalis (TvMGL) and a chemical model system of the reaction were utilized in order to investigate the cofactor-dependent activation of TFM and previously uninvestigated L-difluoromethionine (DFM). The differences in toxicity between TFM and DFM were evaluated against Escherichia coli expressing TvMGL1, as well as the intact human pathogen, T. vaginalis. The relationship between the chemical structure of the reactive intermediates produced from the enzymatic processing of these analogs and their cellular toxicity are discussed.
LanguageEnglish
JournalBiochemical Journal
DOIs
Publication statusPublished - 10 Jun 2011

Fingerprint

Trichomonas vaginalis
Methionine
Toxicity
Biochemistry
Pathogens
Processing
Enzymes
Chemical Models
Pyridoxal Phosphate
Pharmaceutical Chemistry
Poisons
Prodrugs
Ammonia
Sulfhydryl Compounds
Escherichia coli
Chemical activation
Molecules
L-methionine gamma-lyase
trifluoromethionine

Keywords

  • pathogens
  • methyl mercaptan
  • cellular toxicity
  • difluoromethionine
  • trifluoromethionine
  • trichomonas vaginalis

Cite this

@article{e574f6c0f5724a2eb53dbdcfa5d05c45,
title = "Mechanistic studies on the enzymatic processing of fluorinated methionine analogs by Trichomonas vaginalis methionine γ-lyase",
abstract = "L-Trifluoromethionine (TFM), a potential prodrug, was reported to be toxic toward human pathogens that express L-methionine γ-lyase (MGL; EC: 4.4.1.11), a pyridoxal phosphate-containing enzyme that converts L-methionine to α-ketobutyrate, ammonia and methyl mercaptan. It has been hypothesized that the extremely reactive thiocarbonyl difluoride is produced when the enzyme acts upon TFM, resulting in cellular toxicity. The potential application of the fluorinated thiomethyl group in other areas of biochemistry and medicinal chemistry requires additional studies. Therefore a detailed investigation of the theoretical and experimental chemistry and biochemistry of these fluorinated groups (CF3S- and CF2HS-) has been undertaken to trap and identify chemical intermediates produced by enzyme processing of molecules containing these fluorinated moieties. MGL from Trichomonas vaginalis (TvMGL) and a chemical model system of the reaction were utilized in order to investigate the cofactor-dependent activation of TFM and previously uninvestigated L-difluoromethionine (DFM). The differences in toxicity between TFM and DFM were evaluated against Escherichia coli expressing TvMGL1, as well as the intact human pathogen, T. vaginalis. The relationship between the chemical structure of the reactive intermediates produced from the enzymatic processing of these analogs and their cellular toxicity are discussed.",
keywords = "pathogens , methyl mercaptan, cellular toxicity, difluoromethionine, trifluoromethionine, trichomonas vaginalis",
author = "Moya, {Ignace A} and Westrop, {Gareth D} and Coombs, {Graham H} and Honek, {John F}",
year = "2011",
month = "6",
day = "10",
doi = "10.1042/BJ20101986",
language = "English",
journal = "Biochemical Journal",
issn = "0264-6021",

}

TY - JOUR

T1 - Mechanistic studies on the enzymatic processing of fluorinated methionine analogs by Trichomonas vaginalis methionine γ-lyase

AU - Moya, Ignace A

AU - Westrop, Gareth D

AU - Coombs, Graham H

AU - Honek, John F

PY - 2011/6/10

Y1 - 2011/6/10

N2 - L-Trifluoromethionine (TFM), a potential prodrug, was reported to be toxic toward human pathogens that express L-methionine γ-lyase (MGL; EC: 4.4.1.11), a pyridoxal phosphate-containing enzyme that converts L-methionine to α-ketobutyrate, ammonia and methyl mercaptan. It has been hypothesized that the extremely reactive thiocarbonyl difluoride is produced when the enzyme acts upon TFM, resulting in cellular toxicity. The potential application of the fluorinated thiomethyl group in other areas of biochemistry and medicinal chemistry requires additional studies. Therefore a detailed investigation of the theoretical and experimental chemistry and biochemistry of these fluorinated groups (CF3S- and CF2HS-) has been undertaken to trap and identify chemical intermediates produced by enzyme processing of molecules containing these fluorinated moieties. MGL from Trichomonas vaginalis (TvMGL) and a chemical model system of the reaction were utilized in order to investigate the cofactor-dependent activation of TFM and previously uninvestigated L-difluoromethionine (DFM). The differences in toxicity between TFM and DFM were evaluated against Escherichia coli expressing TvMGL1, as well as the intact human pathogen, T. vaginalis. The relationship between the chemical structure of the reactive intermediates produced from the enzymatic processing of these analogs and their cellular toxicity are discussed.

AB - L-Trifluoromethionine (TFM), a potential prodrug, was reported to be toxic toward human pathogens that express L-methionine γ-lyase (MGL; EC: 4.4.1.11), a pyridoxal phosphate-containing enzyme that converts L-methionine to α-ketobutyrate, ammonia and methyl mercaptan. It has been hypothesized that the extremely reactive thiocarbonyl difluoride is produced when the enzyme acts upon TFM, resulting in cellular toxicity. The potential application of the fluorinated thiomethyl group in other areas of biochemistry and medicinal chemistry requires additional studies. Therefore a detailed investigation of the theoretical and experimental chemistry and biochemistry of these fluorinated groups (CF3S- and CF2HS-) has been undertaken to trap and identify chemical intermediates produced by enzyme processing of molecules containing these fluorinated moieties. MGL from Trichomonas vaginalis (TvMGL) and a chemical model system of the reaction were utilized in order to investigate the cofactor-dependent activation of TFM and previously uninvestigated L-difluoromethionine (DFM). The differences in toxicity between TFM and DFM were evaluated against Escherichia coli expressing TvMGL1, as well as the intact human pathogen, T. vaginalis. The relationship between the chemical structure of the reactive intermediates produced from the enzymatic processing of these analogs and their cellular toxicity are discussed.

KW - pathogens

KW - methyl mercaptan

KW - cellular toxicity

KW - difluoromethionine

KW - trifluoromethionine

KW - trichomonas vaginalis

UR - http://www.scopus.com/inward/record.url?scp=80052167717&partnerID=8YFLogxK

U2 - 10.1042/BJ20101986

DO - 10.1042/BJ20101986

M3 - Article

JO - Biochemical Journal

T2 - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

ER -